ArticleBMC nephrology2025
Peritoneal dialysis-associated peritonitis caused by acremonium sclerotigenum: a case report.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAcremonium sclerotigenum exhibits antagonistic properties against various detrimental organisms, including bacteria, nematodes, and mites. As the predominant species within the Acremonium genus, it is characterized as an opportunistic pathogenic fungus that commonly inhabits soil and plants as a saprotroph. Additionally, it has been identified as the etiological agent of superficial infections, such as onychomycosis, and, less frequently, invasive infections. CASE PRESENTATION: This study presents a unique case involving a 79-year-old male who developed peritoneal dialysis-associated peritonitis (PDAP) attributed to Acremonium sclerotigenum. To the best of our knowledge, this represents the first documented instance of PDAP caused by this fungal species.
conclusionThe identification of pathogens is essential for diagnosing PDAP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.